{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T16:24:28Z","timestamp":1791995068953,"version":"4.4.0"},"reference-count":61,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2006,7,1]],"date-time":"2006-07-01T00:00:00Z","timestamp":1151712000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,7,1]],"date-time":"2006-07-01T00:00:00Z","timestamp":1151712000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Physiology & Neurobiology"],"published-print":{"date-parts":[[2006,7]]},"DOI":"10.1016\/j.resp.2005.11.010","type":"journal-article","created":{"date-parts":[[2006,1,7]],"date-time":"2006-01-07T07:22:01Z","timestamp":1136618521000},"page":"356-362","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Current and future peripherally-acting antitussives"],"prefix":"10.1016","volume":"152","author":[{"given":"Peter V.","family":"Dicpinigaitis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.resp.2005.11.010_bib1","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1183\/09031936.97.10081892","article-title":"The role of tachykinin receptor antagonists in the prevention of bronchial hyperresponsiveness, airway inflammation and cough","volume":"10","author":"Advenier","year":"1997","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.resp.2005.11.010_bib2","doi-asserted-by":"crossref","first-page":"209","DOI":"10.2165\/00044011-200222040-00001","article-title":"Therapeutic use of levocloperastine as an antitussive agent","volume":"22","author":"Aliprandi","year":"2002","journal-title":"Clin. Drug Invest."},{"key":"10.1016\/j.resp.2005.11.010_bib3","first-page":"133","article-title":"Levocloperastine in the treatment of chronic nonproductive cough: comparative efficacy versus standard antitussive agents","volume":"30","author":"Aliprandi","year":"2004","journal-title":"Drugs Exp. Clin. Res."},{"key":"10.1016\/j.resp.2005.11.010_bib4","first-page":"1163","article-title":"Clinical trials with the new antitussive levodropropizine in adult bronchitic patients","volume":"38","author":"Allegra","year":"1988","journal-title":"Arzneimittel-Forschung"},{"key":"10.1016\/j.resp.2005.11.010_bib5","first-page":"273","article-title":"Clinical trial of the efficacy and safety of moguisteine in patients with cough associated with chronic respiratory diseases","volume":"19","author":"Aversa","year":"1993","journal-title":"Drugs Exp. Clin. Res."},{"key":"10.1016\/j.resp.2005.11.010_bib6","series-title":"Phytopharmaka III","first-page":"151","article-title":"Experimental and clinical methodologies in efficacy of expectorants using the example of guaifenesin.","author":"Ayres","year":"1997"},{"key":"10.1016\/j.resp.2005.11.010_bib7","series-title":"Pulmonary and Critical Care Pharmacology and Therapeutics","first-page":"673","article-title":"Pharmacologic treatment of cough","author":"Banner","year":"1996"},{"key":"10.1016\/j.resp.2005.11.010_bib8","first-page":"113","article-title":"Protective effect of levodropropizine against cough induced by inhalation of nebulized distilled water in patients with obstructive lung disease","volume":"18","author":"Bariffi","year":"1992","journal-title":"Drugs Exp. Clin. Res."},{"key":"10.1016\/j.resp.2005.11.010_bib9","first-page":"93","article-title":"The efficacy and safety of moguisteine in comparison with codeine phosphate in patients with chronic cough","volume":"50","author":"Barnabe","year":"1995","journal-title":"Monaldi Arch. Chest Dis."},{"key":"10.1016\/j.resp.2005.11.010_bib10","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1111\/j.1476-5381.1994.tb17145.x","article-title":"Peripheral and central sites of action of GABA-B agonists to inhibit the cough reflex in the cat and guinea pig","volume":"113","author":"Bolser","year":"1994","journal-title":"Br. J. Pharmacol."},{"issue":"157","key":"10.1016\/j.resp.2005.11.010_bib11","first-page":"1","article-title":"Ambulatory care visits to physician offices, hospital outpatient departments, and emergency departments: United States, 1999\u20132000","volume":"13","author":"Burt","year":"2004","journal-title":"Vital Health Stat."},{"key":"10.1016\/j.resp.2005.11.010_bib12","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/35040576","article-title":"Bidirectional control of airway responsiveness by endogenous cannabinoids","volume":"408","author":"Calignano","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.resp.2005.11.010_bib13","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1006\/pupt.1997.0083","article-title":"Efficacy and tolerability of levodropropizine in adult patients with nonproductive cough. Comparison with dextromethorphan","volume":"10","author":"Catena","year":"1997","journal-title":"Pulm. Pharmacol."},{"key":"10.1016\/j.resp.2005.11.010_bib14","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/0165-6147(93)90110-6","article-title":"GABA-B receptors in the lung","volume":"14","author":"Chapman","year":"1993","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.resp.2005.11.010_bib15","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.ejphar.2003.11.048","article-title":"Antitussive activity of the tachykinin NK1 receptor antagonist, CP-99994, in dogs","volume":"485","author":"Chapman","year":"2004","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.resp.2005.11.010_bib16","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1177\/106002809603001106","article-title":"Use of baclofen to suppress cough induced by agiotensin-converting enzyme inhibition","volume":"30","author":"Dicpinigaitis","year":"1996","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.resp.2005.11.010_bib17","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1002\/j.1552-4604.1998.tb04436.x","article-title":"Inhibition of capsaicin-induced cough by the \u03b3-aminobutyric acid agonist baclofen","volume":"38","author":"Dicpinigaitis","year":"1998","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.resp.2005.11.010_bib18","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1006\/pupt.2000.0274","article-title":"Effect of the cyclooxygenase-2 inhibitor celecoxib on bronchial responsiveness and cough reflex sensitivity in asthmatics","volume":"14","author":"Dicpinigaitis","year":"2001","journal-title":"Pulm. Pharmacol. Ther."},{"key":"10.1016\/j.resp.2005.11.010_bib19","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1081\/JAS-120002285","article-title":"Antitussive effect of the leukotriene receptor antagonist zafirlukast in subjects with cough-variant asthma","volume":"39","author":"Dicpinigaitis","year":"2002","journal-title":"J. Asthma"},{"key":"10.1016\/j.resp.2005.11.010_bib20","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S1094-5539(02)00149-9","article-title":"Short- and long-term reproducibility of capsaicin cough challenge testing","volume":"16","author":"Dicpinigaitis","year":"2003","journal-title":"Pulm. Pharmacol. Ther."},{"key":"10.1016\/j.resp.2005.11.010_bib21","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1378\/chest.124.6.2178","article-title":"Effect of guaifenesin on cough reflex sensitivity","volume":"124","author":"Dicpinigaitis","year":"2003","journal-title":"Chest"},{"key":"10.1016\/j.resp.2005.11.010_bib22","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1191\/026921698672930910","article-title":"Benzonatate for opioid-resistant cough in advanced cancer","volume":"12","author":"Doona","year":"1997","journal-title":"Palliat. Med."},{"key":"10.1016\/j.resp.2005.11.010_bib23","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.pupt.2003.08.002","article-title":"Effect of a novel NK1 receptor selective antagonist (NKP608) on citric acid induced cough and airway obstruction","volume":"17","author":"El-Hashim","year":"2004","journal-title":"Pulm. Pharmacol. Ther."},{"key":"10.1016\/j.resp.2005.11.010_bib24","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0011-393X(00)88520-3","article-title":"Effects of amlodipine, nifedipine GITS, and indomethacin on angiotensin-converting enzyme inhibitor-induced cough: a randomized, placebo-controlled, double-masked, crossover study","volume":"60","author":"Fogari","year":"1999","journal-title":"Curr. Ther. Res."},{"key":"10.1016\/j.resp.2005.11.010_bib25","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1038\/nm0796-814","article-title":"Bradykinin-evoked sensitization of airway sensory nerves: a mechanism for ACE-inhibitor cough","volume":"2","author":"Fox","year":"1996","journal-title":"Nat. Med."},{"key":"10.1016\/j.resp.2005.11.010_bib26","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1172\/JCI119187","article-title":"Activation of large conductance potassium channels inhibits the afferent and efferent function of airway sensory nerves in the guinea pig","volume":"99","author":"Fox","year":"1997","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.resp.2005.11.010_bib27","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1183\/09031936.95.08091499","article-title":"Prostanoids and cough response to capsaicin in asthma and chronic bronchitis","volume":"8","author":"Fujimura","year":"1995","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.resp.2005.11.010_bib28","first-page":"303","article-title":"A comparative study of the antitussive activity of levodropropizine and dropropizine in the citric acid-induced cough model in normal subjects","volume":"18","author":"Fumagalli","year":"1992","journal-title":"Drugs Exp. Clin. Res."},{"key":"10.1016\/j.resp.2005.11.010_bib29","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1111\/j.1476-5381.1994.tb13149.x","article-title":"Moguisteine: a novel peripheral non-narcotic antitussive drug","volume":"112","author":"Gallico","year":"1994","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.resp.2005.11.010_bib30","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1164\/rccm.200402-174OC","article-title":"Increased expression of transient receptor potential vanilloid-1 in airway nerves of chronic cough","volume":"170","author":"Groneberg","year":"2004","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.resp.2005.11.010_bib31","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1136\/thx.49.11.1166","article-title":"Effects of inhaled lignocaine and adrenaline on capsaicin-induced cough in humans","volume":"49","author":"Hansson","year":"1994","journal-title":"Thorax"},{"key":"10.1016\/j.resp.2005.11.010_bib32","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1124\/jpet.300.1.314","article-title":"Nonpeptide tachykinin receptor antagonists. III. SB 235375, a low central nervous system-penetrant, potent and selective neurokinin-3 receptor antagonist, inhibits citric acid-induced cough and airways hyperreactivity in guinea pigs","volume":"300","author":"Hay","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.resp.2005.11.010_bib33","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0014-2999(03)02077-6","article-title":"Augmentation of spontaneous cough by enalapril through up-regulation of bradykinin B1 receptors in guinea pigs","volume":"474","author":"Hirata","year":"2003","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.resp.2005.11.010_bib34","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1080\/07853890310010032","article-title":"Thromboxane antagonism and cough in chronic bronchitis","volume":"35","author":"Ishiura","year":"2003","journal-title":"Ann. Med."},{"key":"10.1016\/j.resp.2005.11.010_bib35","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1038\/sj.bjp.0704950","article-title":"Anadamide induces cough in conscious guinea-pigs through VR1 receptors","volume":"137","author":"Jia","year":"2002","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.resp.2005.11.010_bib36","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1358\/dnp.2005.18.3.892761","article-title":"TRPV1 receptor: a target treatment of pain, cough, airway disease and urinary incontinence","volume":"18","author":"Jia","year":"2005","journal-title":"Drug News Perspect."},{"key":"10.1016\/j.resp.2005.11.010_bib37","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0165-6147(00)01458-9","article-title":"Pro-inflammatory effects of substance P: new perspectives for the treatment of airway disease?","volume":"21","author":"Joos","year":"2000","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.resp.2005.11.010_bib38","first-page":"201","article-title":"The antitussive effect of cromakalim in rats is not associated with adenosine triphosphate sensitive K+ channels","volume":"80","author":"Kamei","year":"1993","journal-title":"Res. Commun. Chem. Pathol. Pharmacol."},{"key":"10.1016\/j.resp.2005.11.010_bib39","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.ejphar.2004.06.045","article-title":"Antitussive effect of NS-398, a selective cyclooxygenase-2 inhibitor, in guinea pigs","volume":"497","author":"Kamei","year":"2004","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.resp.2005.11.010_bib40","first-page":"A800","article-title":"Comparative antitussive activity of direct and indirect activators of K+ channels (abstract)","volume":"169","author":"Kotzer","year":"2004","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.resp.2005.11.010_bib41","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1152\/jappl.1995.79.4.1082","article-title":"Inhibition by capsazepine of cough induced by capsaicin and citric acid, but not by hypertonic saline in awake guinea pigs","volume":"79","author":"Lalloo","year":"1995","journal-title":"J. Appl. Physiol."},{"key":"10.1016\/j.resp.2005.11.010_bib42","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0952-0600(92)90033-D","article-title":"Peripheral site of action of levodropropizine in experimentally-induced cough: role of sensory neuropeptides","volume":"5","author":"Lavezzo","year":"1992","journal-title":"Pulm. Pharmacol."},{"key":"10.1016\/j.resp.2005.11.010_bib43","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1183\/09031936.98.12010097","article-title":"Efficacy and safety of levodropropizine and dihydrocodeine on nonproductive cough in primary and metastatic lung cancer","volume":"12","author":"Luporini","year":"1998","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.resp.2005.11.010_bib44","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0140-6736(96)12045-6","article-title":"Thromboxane antagonism and cough induced by angiotensin-converting-enzyme inhibitor","volume":"350","author":"Malini","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.resp.2005.11.010_bib45","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0022-3565(25)12743-2","article-title":"The effect of sulindac on the abnormal cough reflex associated with dry cough","volume":"255","author":"McEwan","year":"1990","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.resp.2005.11.010_bib46","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0014-2999(00)00763-9","article-title":"Role of substance P and tachykinin receptor antagonists in citric acid-induced cough in pigs","volume":"408","author":"Moreaux","year":"2000","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.resp.2005.11.010_bib47","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1183\/09031936.02.00281002","article-title":"Understanding cough","volume":"19","author":"Morice","year":"2002","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.resp.2005.11.010_bib48","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0014-2999(00)00197-7","article-title":"Involvement of ATP-sensitive K(+) channels in the anti-tussive effect of moguisteine","volume":"395","author":"Morita","year":"2000","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.resp.2005.11.010_bib49","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0014-2999(03)02009-0","article-title":"Antitussive effect of WIN 55212-2, a cannabinoid receptor agonist","volume":"474","author":"Morita","year":"2003","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.resp.2005.11.010_bib50","first-page":"927","article-title":"Effects of a thromboxane-synthetase inhibitor in patients with chronic persistent coughing and no airway hyperresponsiveness (article in Japanese)","volume":"35","author":"Nishi","year":"1997","journal-title":"Nihon Kyobu Shikkan Gahhai Zasshi"},{"key":"10.1016\/j.resp.2005.11.010_bib51","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/0024-3205(90)90421-M","article-title":"GABA-receptors in peripheral tissues","volume":"46","author":"Ong","year":"1990","journal-title":"Life Sci."},{"key":"10.1016\/j.resp.2005.11.010_bib52","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/sj.bjp.0705435","article-title":"Inhibition of guinea-pig and human sensory nerve activity and the cough reflex in guinea-pigs by cannabinoid (CB2) receptor activation","volume":"140","author":"Patel","year":"2003","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.resp.2005.11.010_bib53","first-page":"275","article-title":"Practice tips. Treating persistent cough. Try a nebulized mixture of lidocaine and bupivacaine","volume":"48","author":"Peleg","year":"2002","journal-title":"Can. Fam. Physician"},{"key":"10.1016\/j.resp.2005.11.010_bib54","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/S0895-7061(00)00268-5","article-title":"Intermediate but not low doses of aspirin can suppress angiotensin-converting enzyme inhibitor-induced cough","volume":"13","author":"Tenenbaum","year":"2000","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.resp.2005.11.010_bib55","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1136\/thx.2003.012930","article-title":"Antitussive activity of iodo-resiniferatoxin in guinea-pigs","volume":"59","author":"Trevisani","year":"2004","journal-title":"Thorax"},{"key":"10.1016\/j.resp.2005.11.010_bib56","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1378\/chest.105.5.1592","article-title":"Nebulized lidocaine in the treatment of refractory cough","volume":"105","author":"Trochtenburg","year":"1994","journal-title":"Chest"},{"key":"10.1016\/j.resp.2005.11.010_bib57","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1053\/ajem.2001.21724","article-title":"Lidocaine inhalation for cough suppression","volume":"19","author":"Udezue","year":"2001","journal-title":"Am. J. Emerg. Med."},{"key":"10.1016\/j.resp.2005.11.010_bib58","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1016\/S0024-3205(97)00124-0","article-title":"Thromboxane A2 synthetase inhibition suppresses cough induced by angiotensin converting enzyme inhibitors","volume":"60","author":"Umemura","year":"1997","journal-title":"Life Sci."},{"key":"10.1016\/j.resp.2005.11.010_bib59","series-title":"Expectorant Drug Products for Over-the-Counter Human Use: Final Monograph","author":"United States Department of Health and Human Services","year":"1989"},{"key":"10.1016\/j.resp.2005.11.010_bib60","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1096\/fj.04-1990fje","article-title":"Theobromine inhibits sensory nerve activation and cough","volume":"19","author":"Usmani","year":"2005","journal-title":"FASEB J."},{"key":"10.1016\/j.resp.2005.11.010_bib61","series-title":"Pharmacology and Therapeutics in Respiratory Care","first-page":"239","article-title":"Agents that affect mucus and cough","author":"Ziment","year":"1994"}],"container-title":["Respiratory Physiology & Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569904805002818?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569904805002818?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T22:10:31Z","timestamp":1761603031000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1569904805002818"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,7]]},"references-count":61,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,7]]}},"alternative-id":["S1569904805002818"],"URL":"https:\/\/doi.org\/10.1016\/j.resp.2005.11.010","relation":{},"ISSN":["1569-9048"],"issn-type":[{"value":"1569-9048","type":"print"}],"subject":[],"published":{"date-parts":[[2006,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Current and future peripherally-acting antitussives","name":"articletitle","label":"Article Title"},{"value":"Respiratory Physiology & Neurobiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.resp.2005.11.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}